Norfloxacin linked to adverse drug reaction skin hyperpigmentation, reveals IPC's Drug safety alert

Published On 2022-12-01 12:08 GMT   |   Update On 2023-10-20 05:51 GMT
Advertisement

The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed that Norfloxacin which is widely used to treat certain bacterial infections, is linked with adverse drug reaction skin hyperpigmentation.

This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.

For more details, check out the link given below:

Drug Safety Alert: IPC Flags Adverse Reactions Linked To Norfloxacin


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News